Introduction {#sec1-1}
============

Genomics is defined as the study of entire genomes of organisms, including extra-chromosomal DNA such as the mitochondrial genetic material. This field includes intensive efforts to determine the entire DNA sequence of organisms, using fine-scale genetic mapping and DNA sequencing with current and emerging technologies. In contrast, investigating the roles of single genes is a primary focus of genetics. Single gene research does not fall into the definition of genomics unless the aim is to verify the effect that a gene may have on the entire genome's networks and pathways. Genomics has been the main focus in molecular biology, especially after the completion of the sequencing of genomes from several organisms. Genomics tools have already helped in the understanding of several aspects of the genome of cancer cells when compared to normal controls. One important example is the identification of the gene HER2/neu (ErbB-2), which is an oncogene mapped to human chromosome that is over-expressed, or amplified, in \~30% of breast cancer tumors (Slamon et al., 1989). Identification of this molecular characteristic culminated in the development of the drug trastuzumab (Herceptin®) (Paik et al., 2008). Breast cancer patients that are HER2/neu (ErbB-2) positive have increased survival rates when treated with this drug.

Recently, cancer genomes were sequenced and compared with normal cells for leukemia, breast, lung, and other tumor types, using second-generation DNA sequencing technologies (Ley et al., 2008; Stephens et al., 2009; Lee et al., 2010; Pleasance et al., 2010). The purpose was to identify mutations that could give rise to new biomarkers and new therapies for these types of cancers. In addition, the 1,000 Genome Project was recently launched (Butler et al., 2010) with the objective of sequencing the genome of thousands of individuals in a small period of time. In parallel, companies are starting to provide whole genome sequencing services, with the aim of understanding the individual's susceptibility for diseases, including different cancers (Kaye, 2008; Pandi and Premalatha, 2015). Medical science workflow applications consists of large number of tasks which are either complex or simple, also there exists a huge amount of data transfer between the tasks. The tasks of the workflow applications are interdependent and are normally represented using directed acyclic graphs (DAG). Cloud platform is currently considered as the cost-effective distributed computing platform for scientific workflow applications (Hoffa et al., 2008; Sadhasivam and Thangaraj, 2017). Currently, most of the cloud service providers provide the resources to the customers using different billing models and charge the usage either on hourly basis or on minute basis. So scheduling of medical science workflow applications requires the user to properly select the resources (Sahni and Vidyarthi, 2015). However, since there are large number of resources which are dynamic so the workflow application scheduling to cloud resources can be efficiently addressed by using meta-heuristics. The medical workflow application Epigenomics which is used at USC Epigenome center for analyzing the genome sequencing of the human body. It contains sequence of automated operations to collect short DNA segments using high-throughput gene sequencing machines and it uses MAQ software and IlluminiaSolexa genetic analyzer (Gil et al., 2007; Deelman et al., 2015). The relationship between the tasks of the Epigenomic workflow application is modelled using eight levels, with each level containing tasks that perform certain functions. [Figure 1](#F1){ref-type="fig"} shows the workflow structure of the Epigenomics workflow application. This application is a data intensive workflow application and contains both large and small size tasks.

![Sample Structure for Epigenomics Scientific Workflow](APJCP-19-243-g001){#F1}

Materials and Methods {#sec1-2}
=====================

Problem Formulation {#sec2-1}
-------------------

The problem can be formulated to identify a task to resource mapping instance P, such that when calculating the total cost incurred using each compute resource PC, the high cost among all the computer resources is minimized. The primary objective of this work is to derive the metaheuristic optimization for mapping the Epigenomics tasks to the compute resources such that the total cost is minimized.
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Where

C~exe~ = The total execution cost for Epigenomics tasks

C~tx~ = The communication cost between the resources

Epigenomics workflow scheduling for Cancer Diagnosis using Particle Swam Optimization {#sec2-2}
-------------------------------------------------------------------------------------

Particle swarm optimization (PSO) is a population based optimization technique inspired by social behavior of bird flocking (Kennedy and Eberhart, 1995; Balamurugan et al., 2017). It combines self-experiences with social experiences and uses a number of particles that represent a swarm moving around in the search space looking for the best solution. In PSO, each single solution is a "particle" in the search space. All of particles have fitness values which are evaluated by the fitness function to be optimized and velocities which direct the moving of the particles. PSO is initialized with a group of random particles. In every iteration, each particle is updated by the two "best" values. After finding the two best values, the particle updates by velocity and position equations.

Particle velocity and position renewal of PSO {#sec2-3}
---------------------------------------------
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Particle Swarm Optimization Steps {#sec2-4}
---------------------------------

Initialize the particles with random solutionsEvaluate the fitness value of each particle's according to the objective functionIf the current fitness value is better than the previous Pbest , Set current fitness value as new PbestOtherwise keep Previous PbestChoose the global best particle (best particle of all pbest particles)Calculate particles' velocities according equation (4)Update particle's new positions according equation (5)*Repeat from step 2 until stopping criteria are satisfied*.

Improved PSO for Epigenomics scientific workflow application scheduling in Cancer Diagnosis {#sec2-5}
-------------------------------------------------------------------------------------------

In the standard PSO algorithm, the convergence speed of particles is fast, but the adjustments of cognition component and social component make particles search around entire solution. So, the whole swarm will be trapped into a local optimum; and the capacity of swarm jump out of a local optimum is rather weak. In order to avoid being trapped into a local optimum, the new PSO adopts a new information sharing mechanism. The proposed method one can not only record the best positions an individual particle and the whole swarm have experienced, one can also record the worst positions.

Particle velocity and position renewal of EPSO {#sec2-6}
----------------------------------------------
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Results {#sec1-3}
=======

The result is experimented and analyzed with the cloudsim and it consists of 10 resources with different processing speed from Amazon EC2 services. The test has been conducted for the task scheduling problem from 10 processors with 50 tasks. The experimental parameter settings of PSO and IPSO algorithms are shown in [Table 1](#T1){ref-type="table"}.

###### 

Parameters and Its Value for PSO and IPSO

  Parameter description             Parameter value
  --------------------------------- -----------------
  Size of Swarm                     50
  Self-recognition coefficient c1   2
  2 Social coefficient c2           2
  Weight(w)                         0.9
  Iterations                        50

[Figure 3](#F2 F3){ref-type="fig"} plots the computation cost computed by PSO and IPSO over the 50 number of iterations for different sizes of cancer diagnosis Epigenomics workflow applications such as Eigenomics_24, Eigenomics_46, Eigenomics_100 and Eigenomics_997 applications respectively. Initially, the particles are randomly initialized. Therefore, the initial total cost is always high. This initial cost corresponds to the 0th iteration. As the algorithm progresses, the convergence is drastic and it finds a global minima very quickly. The average number of iterations needed for the convergence is seen to be 30-35, for this application environment. It displays that IPSO usually had better average completion time values than PSO.

![Pseudocode of IPSO Algorithm](APJCP-19-243-g010){#F2}
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Comparative Analysis of PSO and IPSO {#sec2-7}
------------------------------------

[Table 2](#T2){ref-type="table"} plots comparison of optimal total cost between PSO based resource selection and IPSO algorithms when varying total data size of a workflow. IPSO achieves 10.39 percentages of improvements for Epigenomics_24 application with 24 tasks processed than the PSO algorithm. For Epigenomics_46 application with 46 tasks and Epigenomics_100 application with 100 tasks, the proposed IPSO method attains 9.89 and 6.26 percentage of improvements respectively. Whereas for Epigenomics_997 application with 997 tasks the proposed IPSO method returns 6.83 percentage of improvements in optimal total computation cost. Clearly, IPSO based mapping has much lower cost as compared to that of the existing PSO based mapping.

###### 

Comparison of Computation Cost with Various Data Size for PSO and IPSO

  Size of Data      PSO     IPSO    Percentage of Improvement
  ----------------- ------- ------- ---------------------------
  Epigenomics_24    31.19   28.01   10.19%
  Epigenomics_46    31.32   28.22   9.89%
  Epigenomics_100   33.03   30.96   6.26%
  Epigenomics_997   58.7    54.69   6.83%

Discussion {#sec1-4}
==========

The burgeoning fields of genomics and epigenomics comprise essential facets of modern cancer research. A single genes and groups of genes from the same pathway have been identified as differentially methylated in cancers, and some have been used as molecular biomarkers in order to identify patients with a better or a worse prognosis. Based on the information, growing evidence indicates that new epigenomic tools will increasingly affect the way to monitor and manage cancer in the future. The Epigenomics scientific workflow application is essentially a data processing pipeline to automate the execution of the various genome sequencing operations or tasks. Cloud platform is a popular distributed computing platform for deploying large scale of Epigenomics scientific workflow applications. Scheduling Epigenomics scientific workflow tasks are a complicated problem in cloud platform. In the proposed method IPSO is achieved better results compared with existing methods. The performance of IPSO is analyzed with different cancer diagnosis tasks.
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